32
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Defective Immune Function of Primary Effusion Lymphoma Cells is Associated with Distinct KSHV Gene Expression Profiles

, , , , , , , , & show all
Pages 1223-1238 | Received 19 Aug 2003, Published online: 03 Aug 2009

Reference

  • Gaidano, G., Capello, D., Fassone, L., Gloghini, A., Cilia, A.M., Ariatti, C., et al. (2000) "Molecular characterization of HHV-8 positive primary effusion lymphoma reveals pathogenetic and histogenetic features of the disease", Journal of Clinical Virology, 16, 215–224.
  • Nador, R.G., Cesarman, E., Chadburn, A., Dawson, D.B., Ansari, M.Q., Sald, J., et al. (1996) "Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus", Blood, 88, 645–656.
  • Fais, F., Gaidano, G., Capello, D., Gloghini, A., Ghiotto, F., Roncella, S., et al. (1999) "Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas", Leukemia, 13, 1093 — 1099.
  • Matolcsy, A., Nador, R.G., Cesarman, E. and Knowles, D.M. (1998) "Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation", American Journal of Pathology, 153, 1609 — 1614.
  • Horenstein, M.G., Nador, R.G., Chadburn, A., Hyjek, EM., Inghirami, G., Knowles, D.M., et al. (1997) "Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8", Blood, 90, 1186 — 1191.
  • Szekely, L., Chen, F., Teramoto, N., Ehlin-Henriksson, B., Pokrovskaja, K., Szeles, A., et al. (1998) "Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-asso-ciated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line", Journal of General Virology, 79, 1445 — 1452.
  • Lee, H., Veazey, R., Williams, K., Li, M., Guo, J., Neipel, F., et al. (1998) "Deregulation of cell growth by the K1 gene of Kaposi's sarcoma- associated herpesvirus", Nature Medicine, 4, 435–440.
  • Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M., et al. (1994) "Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma", Science, 266, 1865–1869.
  • Cesarman, E. and Knowles, D.M. (1999) "The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproli-ferative diseases", Seminars in Cancer Biology, 9, 165 — 174.
  • Chan, P.K., Ng, H.K., Hui, M., Ip, M., Cheung, J.L. and Cheng, A.F. (1999) "Presence of human herpesviruses 6, 7, and 8 DNA sequences in normal brain tissue", Journal of Medicinal Virology, 59,491–495.
  • Chan, P.K., Ng, H.K., Cheung, J.L. and Cheng, A.F. (2000) "Survey for the presence and distribution of human herpesvirus 8 in healthy brain", Journal of Clinical Microbiology, 38, 2772–2773.
  • Viviano, E., Vitale, F., Ajello, F., Perna, A.M., Villafrate, MR., Bonura, F., et al. (1997) "Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily", AIDS, 11, 607 — 612.
  • Whitby, D., Howard, MR., Tenant-Flowers, M., Brink, N.S., Copas, A., Boshoff, C., et al. (1995) "Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected indivi-duals and progression to Kaposi's sarcoma", Lancet, 346, 799–802.
  • Moses, A.V., Fish, K.N., Ruhl, R., Smith, P.P., Strussenberg, J.G., Zhu, L., et al. (1999) "Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8", Journal of Virology, 73, 6892–6902.
  • Dezube, B., Zambela, M., Sage, D., Wang, J. and Fingeroth, J. (2002) "Characterization of Kaposi sarcoma-associated herpes-virus/human herpesvirus-8 infection of human vascular endothelial cells: early events", Blood, 100, 888–896.
  • Blackbourn, D., Lennette, E., Klencke, B., Moses, A., Chandran, B., Weinstein, M., et al. (2000) "The restricted celllar host range of human herpesvirus 8", AIDS, 14, 1123–1133.
  • Poole, L., Yu, Y., Kim, P., Zheng, Q., Pervsner, J. and Hayward, G.S. (2002) "Altered Pattens of Cellular Gene expression in dermal miscrovascular endothelial cells infect with Kaposi's sarcoma-associated herpesvirus", Journal of Virology, 76, 3395–3420.
  • Drexler, HG., Uphoff, CC., Gaidano, G. and Carbone, A. (1998) "Lymphoma cell lines: in vitro models for the study of HHV — 8 + primary effusion lymphomas (body cavity-based lymphomas)", Leukemia, 12, 1507 — 1517.
  • Brander, C., Suscovich, T., Lee, Y., Nguyen, P.T., O'Connor, P., Seebach, J., et al. (2000) "Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus", Journal of Immunology, 165, 2077–2083.
  • Gaidano, G., Gloghini, A., Gattei, V., Rossi, M.F., Cilia, A.M., Godeas, C., et al. (1997) "Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen", Blood, 90, 4894 — 4900.
  • Cesarman, E., Moore, P.S., Rao, PH., Inghirami, G., Knowles, D.M. and Chang, Y. (1995) "In vitro establishment and character-ization of two acquired immunodeficiency syndrome-related lym-phoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences", Blood, 86, 2708 — 2714.
  • Arvanitakis, L., Mesri, E.A., Nador, R.G., Said, J.W., Asch, AS., Knowles D.M., et al. (1996) "Establishment and characterization of a primary effusion (body cavity- based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus", Blood, 88, 2648 —2654.
  • Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes D., et al. (1996) "Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture", Nature Medicine, 2, 342— 346.
  • Boshoff, C., Gao, S.J., Healy, L.E.. Matthews, S., Thomas, A.J., Coignet, L., et al. (1998) "Establishing a KSHV + cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice", Blood, 91, 1671–1679.
  • Jones, D., Ballestas, ME., Kaye, K.M., Gulizia, J.M., Winters, G.L., Fletcher, J., et al. (1998) "Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient", New England Journal of Medicine, 339, 444–449.
  • Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E. and Rickinson, A. (1990) "Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes", Journal of Virology, 64, 4084–4092.
  • Gao, S.J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J., et al. (1996) "KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma", Nature Medicine, 2, 925–928.
  • Rozen, S. and Skaletsky, H.J. (2000) Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, edited by S. Krawetz and S. Misener. Pp.365— 386. Totowa, NJ: Humana Press.
  • Brander, C., Matter-Reissmann, U.B., Jones, N.G., Walker, B.D., Sachs, D.H. and Seebach, J.D. (2001) "Inhibition of human NK cell-mediated cytotoxicity by exposure to ammonium chloride", Journal of Immunological Methods, 252, 1–14.
  • Paulose-Murphy, M., Ha, N.K., Xiang, C., Chen, Y., Gillim, L., Yarchoan, R., et al. (2001) "Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus)", Journal of Virology, 75, 4843–4853.
  • Chen, Y., Dougherty, E. and Bittner, M. (1997) "Ratio-based decision and quantitative analysis of cDNA microarray images", Journal of Biomedical Optics, 2, 364— 374.
  • Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., et al. (2000) "Molecular classification of cutaneous malignant melanoma by gene expression profiling", Nature, 406, 536–540.
  • Dianzani, U., Funaro, A., DiFranco, D., Garbarino, G., Bragardo, M., Redoglia, V., et al. (1994) "Interaction between endothelium and CD4 + CD45RA + lymphocytes. Role of the human CD38 molecule", Journal of Immunology, 153, 952–959.
  • Dianzani, U. and Malavasi, F. (1995) "Lymphocyte adhesion to endothelium", Critical Reviews in Immunology, 15, 167–200.
  • Brander, C., Hartman, K.E., Trocha, AK., Jones, N.G., Johnson, R.P., Korber, B., et al. (1998) "Lack of strong immune selection pressure by the immunodominant, HLA- A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodefi-ciency virus-1 infection", Journal of Clinical Investigation, 101, 2559 — 2566.
  • Fletcher, J.M., Prentice, H.G. and Grundy, J.E. (1998) "Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA", Journal of Immunology, 161, 2365–2374.
  • Blake, N., Haigh, T., Shaka'a, G., Croom-Carter, D. and Rickinson, A. (2000) "The importance of exogenous antigen in priming the human CD8 + T cell response: lessons from the EBV nuclear antigen EBNA1 ", Journal of Immunology, 165, 7078 — 7087.
  • Tomazin, R., Boname, J., Hegde, N.R., Lewinsohn, D.M., Altschuler, Y., Jones, T.R., et al. (1999) "Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4 + T cells", Nature Medicine, 5, 1039 — 1043.
  • Bergmann, C.C., Ramakrishna, C., Kornacki, M. and Stohlman, S.A. (2001) "Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection", Journal of Immunology, 167, 1575–1583.
  • Sun, J.C. and Bevan, M.J. (2003) "Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help", Science, 300, 339 — 342.
  • Moore, P.S., Boshoff, C., Weiss, R.A. and Chang, Y. (1996) "Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV", Science, 274, 1739–1744.
  • Albert-Wolf, M., Meuer, S.C. and Wallich, R. (1991) "Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway", International Immunology, 3, 1335— 1347.
  • Le Guiner, S., Le Drean, E., Labarriere, N., Fonteneau, J.F., Viret, C., Diez, E., et al. (1998) "LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal", European Journal of Immunology, 28, 1322 — 1331.
  • Levy, S., Todd, S.C. and Maecker, H.T. (1998) "CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system", Annual Bevies in Immunology, 16, 89–109.
  • Van Seventer, GA., Shimizu, Y., Horgan, K.J. and Shaw, S. (1990) "The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells", Journal of Immunology, 144, 4579–4586.
  • Witherden, D.A., Boismenu, R. and Havran, W.L. (2000) "CD81 and CD28 costimulate T cells through distinct pathways", Journal of Immunology, 165, 1902 — 1909.
  • Coscoy, L. and Ganem, D. (2000) "Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis", Proceedings of the National Academy of the Sciences of the United States of America, 97, 8051 — 8056.
  • Ishido, S., Choi, J.K., Lee, B.S., Wang, C., DeMaria, M., Johnson, R.P., et al. (2000) "Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 pro-tein", Immunity, 13, 365–374.
  • Boyle, Mi., Vasak, E., Tschuchnigg, M., Turner, J.J., Sculley, T., Penny, R., et al. (1993) "Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immuno-compromise", Blood, 81, 468–474.
  • Carbone, A., Tirelli, U., Gloghini, A., Volpe, R. and Boiocchi, M. (1993) "Human immunodeficiency virus-associated systemic lym-phomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression", Journal of Clinical Oncology, 11, 1674 — 1681.
  • Hu, L., Troyanovsky, B., Zhang, X., Trivedi, P., Ernberg, I. and Klein, G. (2000) "Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma", Cancer Research, 60, 5589–5593.
  • Eisen, MB., Spellman, PT., Brown, P.O. and Botstein, D. (1998) "Cluster analysis and display of genome-wide expression patterns", Proceedings of the National Academy of the Sciences of the United States of America, 95, 14863–14868.
  • Stevenson, F.K., Zhu, D., King, CA., Ashworth, L.J., Kumar, S. and Hawkins, R.E. (1995) "Idiotypic DNA vaccines against B-cell lymphoma", Immunological Reviews, 145, 211 — 228.
  • Ishido, S., Wang, C., Lee, B.S., Cohen. G.B. and Jung, J.U. (2000) "Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins", Journal of Virology, 74, 5300— 5309.
  • Mentzer, Si., Smith, BR., Barbosa, J.A., Crimmins, M.A., Herrmann, S.H. and Burakoff, Si. (1987) "CTL adhesion and antigen recognition are discrete steps in the human CTL-target cell interaction", Journal of Immunology, 138, 1325 — 1330.
  • Shaw, S., Luce, G.E., Quinones, R., Gress, RE., Springer, T.A. and Sanders, M.E. (1986) "Two antigen-independent adhesion pathways used by human cytotoxic T- cell clones", Nature, 323, 262–264.
  • Sperling, AT. and Bluestone, J.A. (1996) "The complexities of T-cell co-stimulation: CD28 and beyond", Immunological Reviews, 153, 155— 182.
  • Robertson, Mi., Caligiuri, M.A., Manley, Ti., Levine, H. and Ritz, J. (1990) "Human natural killer cell adhesion molecules. Differential expression after activation and participation in cyto-lysis", Journal of Immunology, 145, 3194–3201.
  • Sirianni, MC., Vincenzi, L., Topino, S., Giovannetti, A., Mazzetta, F., Libi, F., et al. (2002) "NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma", European Journal of Immunology, 32, 2711 — 2720.
  • Talbot, Si., Weiss, R.A., Kellam, P. and Boshoff, C. (1999) "Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line", Virology, 257, 84–94.
  • Jenner, R.G., Alba, MM., Boshoff, C. and Kellam, P. (2001) "Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays", Journal of Virology, 75, 891— 902.
  • Dittmer, D., Lagunoff, M., Renne, R., Staskus, K., Haase, A. and Ganem, D. (1998) "A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus", Journal of Virology, 72, 8309 — 8315.
  • Burysek, L., Yeow, W.S. and Pitha, P.M. (1999) "Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2)", Journal of Human Virology, 2, 19— 32.
  • Choi, J.K., Lee, B.S., Shim, S.N., Li, M. and Jung, J.U. (2000) "Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome", Journal of Virology, 74, 436–446.
  • Glenn, M., Rainbow, L., Aurad, F., Davison, A. and Schulz, T.F. (1999) "Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus", Journal of Virology, 73, 6953–6963.
  • Sadler, R., Wu, L., Forghani, B., Renne, R., Zhong, W., Herndier, B., et al. (1999) "A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma- associated herpesvirus", Journal of Virology, 73, 5722–5730.
  • Dupin, N., Fisher, C., Kellam, P., Ariad, S., Tulliez, M., Franck, N., et al. (1999) "Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proceedings of the National Academy of the Sciences of the United States of America, 96, 4546 — 4551.
  • Katano, H., Sato, Y., Itoh, H. and Sata, T. (2001) "Expression of human herpesvirus 8 (HHV-8)-encoded immediate early protein, open reading frame 50, in HHV-8-associated diseases", Journal of Human Virology, 4, 96–102.
  • Parravicini, C., Chandran, B., Corbellino, M., Berti, E., Paulli, M., Moore, P.S., et al. (2000) "Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease", American Journal of Pathology, 156, 743–749.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.